Anti-acne cosmetics and cosmeceutical patentometric profile

This study delves into acne vulgaris, a chronic skin condition, marked by inflammation within the pilosebaceous unit. The significant economic burden of acne treatment is reflected in a burgeoning market poised for further expansion. Through patentometric analysis, aiming to identify technological trends, the research underscores the critical role of this method in identifying strategic opportunities within the anti-acne cosmetics and cosmeceuticals domain, pointing out China, the USA, South Korea, and Japan as pivotal in creating and consuming anti-acne technologies. The patent data reveals a pronounced focus on medicine and pharmacology, especially those derived from plant and animal sources. Patent applications have declined post-2017 suggesting shifts in research and development priorities and challenges in pioneering effective products. The applicants' temporal analysis and S-curve reflect the sector's maturity and growth trajectory. Despite the significant economic and societal burden of acne vulgaris, there is a lack of comprehensive studies that integrate patentometric insights with strategic market analysis, particularly focusing on the evolving trends in anti-acne technologies. This study includes the competitiveness indicators provided for the top companies worldwide. These indicators (e.g. patenting activity, technological share, average patent quality, patent strength, etc.) showed the strategic positioning of those actors. Ultimately, the paper proposes that the insights garnered could serve as a foundation for strategic allocation of financial and innovative efforts, underlining the need for advancements in treating acne vulgaris, a condition currently lacking a definitive cure.